RE:Expectations for Next WeekMy wife currently is on Niraparib, a parp inhibitor for recurrent ovarian cancer maintenance. It doesn't usually kill the cancer be can delay it from returning. Anyway, the cost in canadian dollars is $8047 for a box, which is 28 days worth of capsules. Btw, the medicine doesn't even do that much for someone like my wife who is not BRCA or HRD positve. Still, in USD about $80k/year.
SPCEO1 wrote:
Paul also mentioned 10,000 potential patients in the recent presentation. So, if they were able to get 10,000 patients and the drug had a price tag of $10,000, then that is a $100 million in annual revenue. If a price tag of $20,000, $200 million and so on. Does anyone have a good idea of what price range a drug like TH-1902 might be found?